FOXF2 Matched Antibody Pair (450) (APMAB-450LY)

Ryu, J. R., Ahuja, S., Arnold, C. R., Potts, K. G., Mishra, A., Yang, Q., ... & Childs, S. J. (2022). Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer. Proceedings of the National Academy of Sciences, 119(35), e2121333119.

Jia, D., Zhou, Z., Kwon, O. J., Zhang, L., Wei, X., Zhang, Y., ... & Xin, L. (2022). Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. Nature Communications, 13(1), 6828.

Wu, Q., Li, W., & You, C. (2021). The regulatory roles and mechanisms of the transcription factor FOXF2 in human diseases. PeerJ, 9, e10845.

Lu, J. T., Tan, C. C., Wu, X. R., He, R., Zhang, X., Wang, Q. S., ... & Feng, Y. M. (2020). FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-β and miR-182-5p. Cell Death & Differentiation, 27(10), 2973-2987.

He, W., Kang, Y., Zhu, W., Zhou, B., Jiang, X., Ren, C., & Guo, W. (2020). FOXF2 acts as a crucial molecule in tumours and embryonic development. Cell Death & Disease, 11(6), 424.

Liu, L., Chen, G., Chen, T., Shi, W., Hu, H., Song, K., ... & He, Y. (2020). si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway. Stem Cell Research & Therapy, 11, 1-17.

Wang, S., Li, G. X., Tan, C. C., He, R., Kang, L. J., Lu, J. T., ... & Feng, Y. M. (2019). FOXF2 reprograms breast cancer cells into bone metastasis seeds. Nature communications, 10(1), 2707.

Bademci, G., Abad, C., Incesulu, A., Elian, F., Reyahi, A., Diaz-Horta, O., ... & Tekin, M. (2019). FOXF2 is required for cochlear development in humans and mice. Human molecular genetics, 28(8), 1286-1297.

Kang, L. J., Yu, Z. H., Cai, J., He, R., Lu, J. T., Hou, C., ... & Feng, Y. M. (2019). Reciprocal transrepression between FOXF2 and FOXQ1 controls basal‐like breast cancer aggressiveness. The FASEB Journal, 33(5), 6564-6573.

Higashimori, A., Dong, Y., Zhang, Y., Kang, W., Nakatsu, G., Ng, S. S., ... & Yu, J. (2018). Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2–IRF2BPL–β-Catenin Signaling AxisRole of FOXF2 in Gastric Cancer. Cancer research, 78(7), 1643-1656.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-FOXF2 Recombinant Antibody (2G10)

Mouse Anti-FOXF2 Recombinant Antibody (CBXF-0839)

Mouse Anti-FOXF2 Recombinant Antibody (CBXF-3149)

Mouse Anti-FOXF2 Recombinant Antibody (CBXF-0838)

Mouse Anti-FOXF2 Recombinant Antibody (CBXF-3152)

Mouse Anti-FOXF2 Recombinant Antibody (2F5)

Mouse Anti-FOXF2 Recombinant Antibody (4F8)

Mouse Anti-FOXF2 Recombinant Antibody (CBXF-0841)

Mouse Anti-FOXF2 Recombinant Antibody (2D7)

Mouse Anti-FOXF2 Recombinant Antibody (2C7)

Isotype control